| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $17.0M | +168.0% |
| SG&A Expense | $11.6M | +91.5% |
| Pre-tax Income | -$28.2M | -325.8% |
| Income Tax | -$534K | — |
| Net Income | -$27.6M | -121.6% |
| EPS (Basic) | $0.12 | +101.7% |
| EPS (Diluted) | $0.12 | +101.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.5M | -11.0% |
| Current Assets | $41.7M | -33.4% |
| Total Assets | $43.1M | -33.1% |
| Current Liabilities | $6.7M | +154.7% |
| Total Liabilities | $6.8M | +136.9% |
| Stockholders' Equity | $36.2M | -41.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.4M | -64.6% |
| Capital Expenditures | $68K | -71.5% |
| Investing Cash Flow | $19.5M | +143.2% |
| Financing Cash Flow | -$808K | -101.3% |
| Free Cash Flow | -$20.4M | -62.0% |